Ayuda
Ir al contenido

Dialnet


The mechanism of γ-Secretase dysfunction in familial Alzheimer disease

    1. [1] University of Twente

      University of Twente

      Países Bajos

    2. [2] University of Duisburg-Essen

      University of Duisburg-Essen

      Kreisfreie Stadt Essen, Alemania

    3. [3] VIB Center for the Biology of Disease, Leuven, Belgium; Center for Human Genetics (CME) and Leuven Institute for Neurodegenerative Diseases (LIND), University of Leuven (KUL), Leuven, Belgium
    4. [4] Center for Human Genetics (CME) and Leuven Institute for Neurodegenerative Diseases (LIND), University of Leuven (KUL), Leuven, Belgium
    5. [5] Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium
    6. [6] VIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), Leuven, Belgium; VIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), Leuven, Belgium
    7. [7] Switch Laboratory, Department of Cellular and Molecular Medicine, KULeuven, Leuven, Belgium; VIB Switch Laboratory, Flanders Institute for Biotechnology (VIB), Leuven, Belgium
    8. [8] Faculty of Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, AE Enschede, The Netherlands; Vrije Universiteit Brussel, Brussel, Belgium
  • Localización: EMBO journal: European Molecular Biology Organization, ISSN 0261-4189, Vol. 31, Nº. 10, 2012, págs. 2261-2274
  • Idioma: inglés
  • Enlaces
  • Resumen
    • Mutations in presenilin (PSEN) and amyloid precursor protein (APP) cause dominant early-onset Alzheimer's disease (AD), but the mechanism involved is debated. Here, such mutations are shown to alter γ-secretase activity, leading to changes in Aβ peptide cleavage patterns.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno